Literature DB >> 8113822

Is knowing your cholesterol number harmful?

M J Irvine1, A G Logan.   

Abstract

To examine the potential adverse psychological effects of screening for hypercholesterolemia, 287 men working at a motor-car assembly or steel-making plant who were ultimately diagnosed as having hypercholesterolemia and 236 randomly selected normal cholesterol controls from the same plants completed psychological questionnaires at the initial screen and 1-year later. At baseline and before diagnosis, hypercholesterolemic men scored higher on mental health and lower on negative affect than controls (p values < 0.05). One year later no adverse changes on the psychological measures were found irrespective of the type of follow-up care that they were randomly assigned to receive. Surprisingly only about half of the hypercholesterolemic men believed they had hypercholesterolemia at follow-up despite being told otherwise. Baseline scores of those who did not accept the label (n = 122) [classified as deniers] were higher on measures of positive affect and lower on measures of negative effect than those of hypercholesterolemic men who accepted the disease label (n = 73) (p values < 0.05). Moreover they held more negative attitudes towards dietary change at baseline (p < 0.03), made fewer dietary changes (p values < 0.05), and had a lesser change in total cholesterol. We conclude that a hypercholesterolemia detection and treatment program conducted in a working adult population had no adverse psychological consequences. It did, however, reveal a large subset of hypercholesterolemic men who did not accept the label despite being told they had this problem. Denial was a significant barrier to health behaviour change and may represent a maladaptive coping style for men at risk of cardiovascular disease. High cholesterol appears to be associated with better mental health and those who deny having hypercholesterolemia have the best mental health. The multifarious relationship between cholesterol, mental health, and denial deserves further study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113822     DOI: 10.1016/0895-4356(94)90018-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Cholesterol and coronary heart disease: screening and treatment.

Authors:  S Ebrahim; G D Smith; C McCabe; N Payne; M Pickin; T A Sheldon; F Lampe; F Sampson; S Ward; G Wannamthee
Journal:  Qual Health Care       Date:  1998-12

2.  Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction.

Authors:  John Z Ayanian; Bruce E Landon; Mary Beth Landrum; James R Grana; Barbara J McNeil
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

3.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.

Authors:  D Bhatnagar; J Morgan; S Siddiq; M I Mackness; J P Miller; P N Durrington
Journal:  BMJ       Date:  2000-12-16

4.  Health Status and Psychological Distress in Patients with Non-compaction Cardiomyopathy: The Role of Burden Related to Symptoms and Genetic Vulnerability.

Authors:  Corline Brouwers; Kadir Caliskan; Sven Bos; Jeanine E Roeters Van Lennep; Eric J Sijbrands; Willem J Kop; Susanne S Pedersen
Journal:  Int J Behav Med       Date:  2015-12

5.  Health-related quality of life in cardiac patients with dyslipidemia and hypertension.

Authors:  Lyne Lalonde; Annette O'Connor; Lawrence Joseph; Steven A Grover
Journal:  Qual Life Res       Date:  2004-05       Impact factor: 4.147

6.  Self-reported diabetes is associated with self-management behaviour: a cohort study.

Authors:  Baiju R Shah; Douglas G Manuel
Journal:  BMC Health Serv Res       Date:  2008-07-07       Impact factor: 2.655

7.  Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Christopher M Gamboa; Lisandro D Colantonio; Todd M Brown; April P Carson; Monika M Safford
Journal:  J Am Heart Assoc       Date:  2017-05-10       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.